Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


Small molecule BKM1972 inhibits human prostate cancer growth and overcomes docetaxel resistance in intraosseous models.

Chen Y, Gera L, Zhang S, Li X, Yang Y, Mamouni K, Wu AY, Liu H, Kucuk O, Wu D.

Cancer Lett. 2019 Apr 1;446:62-72. doi: 10.1016/j.canlet.2019.01.010. Epub 2019 Jan 18.


PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin.

Mouly L, Mamouni K, Gence R, Cristini A, Cherier J, Castinel A, Legrand M, Favre G, Sordet O, Monferran S.

Cell Death Dis. 2018 Sep 12;9(9):931. doi: 10.1038/s41419-018-0981-3.


A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models.

Mamouni K, Zhang S, Li X, Chen Y, Yang Y, Kim J, Bartlett MG, Coleman IM, Nelson PS, Kucuk O, Wu D.

Neoplasia. 2018 Aug;20(8):789-799. doi: 10.1016/j.neo.2018.06.003. Epub 2018 Jul 4.


Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer.

Yang Y, Mamouni K, Li X, Chen Y, Kavuri S, Du Y, Fu H, Kucuk O, Wu D.

Mol Cancer Ther. 2018 Sep;17(9):1859-1870. doi: 10.1158/1535-7163.MCT-17-1176. Epub 2018 Jun 15.


Sensitive liquid chromatography/tandem mass spectrometry method for the determination of two novel highly lipophilic anticancer drug candidates in rat plasma and tissues.

Hooshfar S, Linzey MR, Wu D, Gera L, Mamouni K, Li X, Chen Y, Yang Y, Olorunyolemi O, Bartlett MG.

Biomed Chromatogr. 2018 Feb;32(2). doi: 10.1002/bmc.4064. Epub 2017 Sep 12.


Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644: an aminobisphosphonate derivative.

Zhang S, Gera L, Mamouni K, Li X, Chen Z, Kucuk O, Wu D.

Oncotarget. 2016 May 10;7(19):27489-98. doi: 10.18632/oncotarget.8481.


Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI.

Pu F, Salarian M, Xue S, Qiao J, Feng J, Tan S, Patel A, Li X, Mamouni K, Hekmatyar K, Zou J, Wu D, Yang JJ.

Nanoscale. 2016 Jul 7;8(25):12668-82. doi: 10.1039/c5nr09071g. Epub 2016 Mar 10.


RhoB promotes γH2AX dephosphorylation and DNA double-strand break repair.

Mamouni K, Cristini A, Guirouilh-Barbat J, Monferran S, Lemarié A, Faye JC, Lopez BS, Favre G, Sordet O.

Mol Cell Biol. 2014 Aug;34(16):3144-55. doi: 10.1128/MCB.01525-13. Epub 2014 Jun 9.


RhoB promotes cancer initiation by protecting keratinocytes from UVB-induced apoptosis but limits tumor aggressiveness.

Meyer N, Peyret-Lacombe A, Canguilhem B, Médale-Giamarchi C, Mamouni K, Cristini A, Monferran S, Lamant L, Filleron T, Pradines A, Sordet O, Favre G.

J Invest Dermatol. 2014 Jan;134(1):203-212. doi: 10.1038/jid.2013.278. Epub 2013 Jun 21.

Supplemental Content

Loading ...
Support Center